AR017877A1 - Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo - Google Patents
Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodoInfo
- Publication number
- AR017877A1 AR017877A1 ARP980106418A ARP980106418A AR017877A1 AR 017877 A1 AR017877 A1 AR 017877A1 AR P980106418 A ARP980106418 A AR P980106418A AR P980106418 A ARP980106418 A AR P980106418A AR 017877 A1 AR017877 A1 AR 017877A1
- Authority
- AR
- Argentina
- Prior art keywords
- mastitis
- type
- mothers
- treatment
- xantofila
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 208000004396 mastitis Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 3
- 235000013793 astaxanthin Nutrition 0.000 abstract 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 3
- 229940022405 astaxanthin Drugs 0.000 abstract 3
- 239000001168 astaxanthin Substances 0.000 abstract 3
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 241001474374 Blennius Species 0.000 abstract 1
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 235000013312 flour Nutrition 0.000 abstract 1
- 235000008210 xanthophylls Nutrition 0.000 abstract 1
- 150000003735 xanthophylls Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Se describen un método para el tratamiento profiláctico de la mastitis en madres de mamíferos, inclusive madres humanas. El método comprende laadministracion a dichas madres de dosis profilácticamente efectivas de un medicamento humano o veterinarioque contiene por lo menos un tipo de xantofilas, talcomo la astaxantina. Preferentemente la astaxantina existe en una forma esterificada con ácidos grasos, por ejemplo, en la forma de una harina de algasproducida mediante el cultivo del algaHeamatoc occus sp. Además, se revela el uso de por lo menos un tipo de xantofinas, tal como la astaxantina, para lapreparacion de un medicamento humano o veterinario para el tratamiento profiláctico de la mastitis en madres de mamíferos, incluyendohumanas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704693A SE511237C2 (sv) | 1997-12-16 | 1997-12-16 | Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017877A1 true AR017877A1 (es) | 2001-10-24 |
Family
ID=20409414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106418A AR017877A1 (es) | 1997-12-16 | 1998-12-16 | Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6335015B1 (es) |
| EP (1) | EP1049460B1 (es) |
| JP (1) | JP2002508318A (es) |
| AR (1) | AR017877A1 (es) |
| AT (1) | ATE239457T1 (es) |
| AU (1) | AU743198B2 (es) |
| CA (1) | CA2314170C (es) |
| DE (1) | DE69814467D1 (es) |
| NO (1) | NO327301B1 (es) |
| NZ (1) | NZ504801A (es) |
| SE (1) | SE511237C2 (es) |
| WO (1) | WO1999030701A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903336D0 (sv) * | 1999-09-17 | 1999-09-17 | Astacarotene Ab | DNA construct and its use |
| SE9903619D0 (sv) * | 1999-10-07 | 1999-10-07 | Astacarotene Ab | Use and method of treatment |
| US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
| CN101845009B (zh) | 2002-07-29 | 2012-10-03 | 卡达克斯药物公司 | 用于抑制和改善疾病的类胡萝卜素结构类似物 |
| US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
| US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
| US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
| US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
| US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
| US7375133B2 (en) | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| WO2005102356A1 (en) * | 2004-04-14 | 2005-11-03 | Hawaii Biotech, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| DK1806982T3 (en) | 2004-09-28 | 2018-11-19 | Avivagen Inc | COMPOSITIONS AND PROCEDURES FOR PROMOTING WEIGHT ADMINISTRATION AND FOOD TRAFFIC |
| US7247752B2 (en) | 2004-10-01 | 2007-07-24 | Cardax Pharmaceuticals, Inc. | Methods for the synthesis of astaxanthin |
| US10449247B2 (en) | 2007-10-26 | 2019-10-22 | Avivagen Inc. | Compositions and methods for enhancing immune response |
| AU2010242502B2 (en) | 2009-04-30 | 2016-11-10 | Avivagen Inc. | Methods and compositions for improving the health of animals |
| WO2010124392A1 (en) * | 2009-04-30 | 2010-11-04 | Chemaphor Inc. | Methods, compositions, and kits for the treatment of inflammatory conditions |
| US20230079333A1 (en) * | 2020-02-18 | 2023-03-16 | Avivagen Inc. | Supplemented animal feeds for mammals |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2619491B2 (ja) | 1988-08-11 | 1997-06-11 | サントリー株式会社 | アスタキサンチン含有組成物 |
| JPH10513444A (ja) * | 1995-02-03 | 1998-12-22 | ビーエーエスエフ アクチェンゲゼルシャフト | 皮膚疾患の治療のための医薬品の製造のためのカロチノイドの使用 |
| JPH09124470A (ja) | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
| SE506191C2 (sv) | 1996-03-27 | 1997-11-17 | Astacarotene Ab | Medel och sätt för att öka produktionen av/hos däggdjur |
-
1997
- 1997-12-16 SE SE9704693A patent/SE511237C2/sv not_active IP Right Cessation
-
1998
- 1998-12-10 EP EP98963702A patent/EP1049460B1/en not_active Expired - Lifetime
- 1998-12-10 WO PCT/SE1998/002279 patent/WO1999030701A1/en not_active Ceased
- 1998-12-10 DE DE69814467T patent/DE69814467D1/de not_active Expired - Lifetime
- 1998-12-10 CA CA002314170A patent/CA2314170C/en not_active Expired - Fee Related
- 1998-12-10 NZ NZ504801A patent/NZ504801A/en not_active IP Right Cessation
- 1998-12-10 US US09/589,594 patent/US6335015B1/en not_active Expired - Lifetime
- 1998-12-10 JP JP2000538684A patent/JP2002508318A/ja active Pending
- 1998-12-10 AU AU18972/99A patent/AU743198B2/en not_active Ceased
- 1998-12-10 AT AT98963702T patent/ATE239457T1/de not_active IP Right Cessation
- 1998-12-16 AR ARP980106418A patent/AR017877A1/es unknown
-
2000
- 2000-06-14 NO NO20003042A patent/NO327301B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6335015B1 (en) | 2002-01-01 |
| NO327301B1 (no) | 2009-06-02 |
| ATE239457T1 (de) | 2003-05-15 |
| NO20003042D0 (no) | 2000-06-14 |
| NO20003042L (no) | 2000-06-14 |
| CA2314170A1 (en) | 1999-06-24 |
| AU1897299A (en) | 1999-07-05 |
| SE9704693D0 (sv) | 1997-12-16 |
| WO1999030701A1 (en) | 1999-06-24 |
| EP1049460A1 (en) | 2000-11-08 |
| EP1049460B1 (en) | 2003-05-07 |
| CA2314170C (en) | 2008-01-29 |
| SE9704693L (sv) | 1999-06-17 |
| DE69814467D1 (de) | 2003-06-12 |
| SE511237C2 (sv) | 1999-08-30 |
| AU743198B2 (en) | 2002-01-24 |
| NZ504801A (en) | 2002-05-31 |
| JP2002508318A (ja) | 2002-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR017877A1 (es) | Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo | |
| AR003108A1 (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento, composicion farmaceutica que los contienen, el uso de los mismos para la preparación de un medicamento. | |
| ES2177538T3 (es) | Espiro piperidinas y homologos que promueven la liberacion de la hormona del crecimiento. | |
| ATE232393T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung | |
| DK1011653T3 (da) | Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser | |
| ATE108334T1 (de) | Immunotherapeutisches zubereitungen für die behandlung von aids. | |
| AR032248A1 (es) | Preparacion para mejorar la asimilacion de los alimentos | |
| DK165903C (da) | Farmaceutisk praeparat mod acne | |
| SE0950392L (sv) | Sammansättning för behandling av hudåkommor | |
| AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
| US20210315930A1 (en) | Nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation | |
| SE9704590D0 (sv) | Method of increasing the production and improving the quality of semen | |
| PT651654E (pt) | Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa | |
| AR045070A1 (es) | Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico | |
| SE9803541D0 (sv) | Treatment of dyspepsia | |
| CN108635253A (zh) | 一种婴幼儿蛋黄油化妆品 | |
| ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
| ES2145114T3 (es) | Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias. | |
| ES2135023T3 (es) | Utilizacion de un decapeptido con actividad de tipo benzodiazepina para la preparacion de medicamentos y complementos alimentarios. | |
| CN107510767A (zh) | 一种固肾补肾组合药物 | |
| ZA202306644B (en) | Application of chinese liquor in the preparation of medicines for improving intestinal barrier functions and gut microbiota | |
| Saha et al. | Mycobacterium chelonae infection complicating cosmetic facial surgery | |
| ES2112517T3 (es) | Antibioticos ge 37468 a, b y c. | |
| AU2001278375A1 (en) | Composition for pharmaceutical and cosmetic products | |
| YU35891A (sh) | Postupak za dobijanje farmaceutskih preparata medicinske kozmetike ili kozmetičkih proizvoda koji sadrže gama-l-glutamil taurin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |